Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00708162
What this trial is testing

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir

Who this might be right for
HIV Infection
Gilead Sciences 724
Large-scale testing (Phase 3)Study completedNCT01435018
What this trial is testing

Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 334
Not applicableStudy completedNCT04318210
What this trial is testing

Open Label Extension (OLE) of the TDF2 Study, Botswana

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 229
Not applicableStudy completedNCT04638686
What this trial is testing

REal-Life Cohort With DOlutegravir + LAmivudina

Who this might be right for
HIV-1-infection
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 185
Testing effectiveness (Phase 2)Study completedNCT00651066
What this trial is testing

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Who this might be right for
HIV InfectionsTuberculosis
French National Agency for Research on AIDS and Viral Hepatitis 47
Not applicableStudy completedNCT06518213
What this trial is testing

Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit

Who this might be right for
HIV Infections
University Hospital for Infectious Diseases, Croatia 112
Large-scale testing (Phase 3)Not Yet RecruitingNCT07792096
What this trial is testing

An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and Adolescents With HIV in Africa

Who this might be right for
HIV Infection
University College, London 800
Not applicableStudy completedNCT03416881
What this trial is testing

Older HIV-infected Adults and Drug Interactions: French Cross-sectional Study

Who this might be right for
HIV Infections
University Hospital, Caen 13,225
Large-scale testing (Phase 3)Study completedNCT00044577
What this trial is testing

New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus IHIV Infection
ViiV Healthcare 166
Large-scale testing (Phase 3)Study completedNCT00021554
What this trial is testing

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Who this might be right for
HIV Infections
Hoffmann-La Roche 525
Not applicableStudy completedNCT04862975
What this trial is testing

Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

Who this might be right for
Lactating Women on Select DOIBreastmilk Fed Infants of Mothers on Select DOIHIV Infections
Duke University 164
Testing effectiveness (Phase 2)Study completedNCT04552795
What this trial is testing

Pilot Study to Investigate the Safety and Feasibility of AntiRetroviral Therapy for Alzheimer's Disease

Who this might be right for
Alzheimer Disease, Early Onset
The University of Texas Health Science Center at San Antonio 12
Testing effectiveness (Phase 2)WithdrawnNCT02438345
What this trial is testing

PRO 140 for Human Immunodeficiency Virus

Who this might be right for
HIV
Drexel University
Not applicableNot Yet RecruitingNCT05222945
What this trial is testing

Determine the Cartography of Virologic Reservoir Related to Antiretroviral Concentrations in HIV-1 Chronic Patients Treated by a First Line Treatment Containing bictégravir, Emtricitabine and ténofovir alafénamide

Who this might be right for
HIV-1-infection
ANRS, Emerging Infectious Diseases 34
Early research (Phase 1)Study completedNCT00001644
What this trial is testing

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableStudy completedNCT01645865
What this trial is testing

Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost (Kenya)

Who this might be right for
HIVHIV InfectionsAIDS+1 more
Elizabeth Glaser Pediatric AIDS Foundation 600
Post-approval studies (Phase 4)Ended earlyNCT01245101
What this trial is testing

Addition of Raltegravir to Established Antiretroviral Suppressive Therapy

Who this might be right for
HIV
University of Miami 15
Not applicableStudy completedNCT00197639
What this trial is testing

Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand

Who this might be right for
HIV Infection
Harvard School of Public Health (HSPH) 19
Large-scale testing (Phase 3)UnknownNCT03988452
What this trial is testing

Nucleosides And Darunavir/Dolutegravir In Africa

Who this might be right for
Human Immunodeficiency Virus
Makerere University 465
Not applicableStudy completedNCT01529125
What this trial is testing

Safety and Metabolic Study of Highly Active Antiretroviral Therapy (HAART) in Malnourished Children With HIV

Who this might be right for
KwashiorkorMarasmusSevere Acute Malnutrition+1 more
Washington University School of Medicine 42
Next Page